🌐 XmAb819
XmAb819 is a clinical-stage biotechnology organization developing an investigational cancer immunotherapy targeting ENPP3 and CD47.
2
Signals
4
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Decker Outdoor Tumbles on Guidance; Amex to Cut Workforce | Stock Movers | expired | Health | involved | 100% | |
| Allergan Aesthetics presents data on facial injectables at Dubai | expired | Health | involved | 100% |